{"filings":[{"id":1509036,"accession_number":"0001104659-26-081616","cik":1682639,"company_name":"HYPERION DEFI, INC.","ticker":"HYPD","form_type":"8-K","filed_at":"2026-07-08T13:01:16+00:00","items":["5.02","9.01"],"status":"ready","headline":"Hyperion DeFi signs new employment pacts with CEO Jung, CFO Knox, GC Rubenstein","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["CEO Jung gets target bonus upon termination within 12 months after change in control, plus prior severance.","CFO Knox and GC Rubenstein get 12 months base salary, health benefits, and target bonus if termination within 12 months after change in control.","Equity awards time-vesting accelerates upon change in control for all three executives.","Knox eligible for bonus up to 75% of base salary; Rubenstein up to 35%; Rubenstein base salary set at $325,000."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.45,"calibrated_materiality_score":0.45,"market_cap_usd":51081607.20277778,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":1387517,"accession_number":"0001104659-26-079856","cik":1682639,"company_name":"HYPERION DEFI, INC.","ticker":"HYPD","form_type":"8-K","filed_at":"2026-07-01T20:01:23+00:00","items":["5.07","9.01"],"status":"ready","headline":"Hyperion DeFi annual meeting elects directors, ratifies auditor, say-on-pay passes; written consent proposal fails","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["All five director nominees elected with >1.5M votes for each; broker non-votes ~4.2M.","Ratification of CBIZ CPAs P.C. as auditor approved with 5.8M for, 48.6K against.","Advisory vote on executive compensation passed with 1.47M for, 164.5K against.","Proposal to allow stockholder action by written consent failed to receive necessary votes.","Adjournment proposal approved to allow further solicitation if needed."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.15,"market_cap_usd":51081607.20277778,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":889202,"accession_number":"0001104659-26-071001","cik":1682639,"company_name":"HYPERION DEFI, INC.","ticker":"HYPD","form_type":"8-K","filed_at":"2026-06-05T20:30:37+00:00","items":["8.01","9.01"],"status":"ready","headline":"Hyperion DeFi to wind down Native Markets and Felix agreements; reposition 800k HYPE tokens","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Native Markets terminated Temporary Use Agreement effective June 18, 2026; Company received all fees and 300k HYPE tokens returned on June 3.","HAUS Agreement with Felix Foundation being wound down; 500k HYPE tokens to be unstaked on June 22, final payments expected by June 29.","Previously disclosed asset values: ~$10.4M from Native Markets and ~$18.3M from Felix (as of March 31, 2026).","Combined ~800k HYPE tokens will be repositioned to strategies management expects to be more profitable."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":51081607.20277778,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":77448,"accession_number":"0001104659-26-060677","cik":1682639,"company_name":"HYPERION DEFI, INC.","ticker":"HYPD","form_type":"8-K","filed_at":"2026-05-14T11:00:32+00:00","items":["2.02","7.01","8.01","9.01"],"status":"ready","headline":"Hyperion DeFi Q1 2026 record net income $8.84M; raises FY 2026 adjusted gross profit guidance ~20%","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["GAAP net income $8.84M vs. loss of $39.8M in Q4 2025; non-GAAP adjusted EBITDA $19.5M.","Non-GAAP adjusted gross profit $959.6K, up 17% QoQ from $821K; GAAP gross profit $244.3K.","Treasury holds >2M HYPE, 1.92M KNTQ, and 10M HPL tokens as of May 11, 2026.","Company raised full-year 2026 adjusted gross profit guidance by ~20%.","Chardan Capital purchased 132,249 shares in option exercise, net proceeds ~$0.4M."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":51081607.20277778,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":94668,"accession_number":"0001104659-26-056237","cik":1682639,"company_name":"HYPERION DEFI, INC.","ticker":"HYPD","form_type":"8-K","filed_at":"2026-05-06T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"Hyperion DeFi prices 2.78M share offering at $3.60, expects ~$10M gross","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Offers 2,777,778 shares at $3.60 per share; sole underwriter Chardan Capital Markets.","Net proceeds ~$8.7M (~$10.1M if underwriter option exercised in full).","Underwriter granted 30-day option to purchase up to 416,666 additional shares.","Closing expected May 7, 2026; proceeds to fund HYPE treasury strategy and working capital.","Offering under effective shelf registration S-3 (File 333-291570)."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":51081607.20277778,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":107220,"accession_number":"0001104659-26-034858","cik":1682639,"company_name":"HYPERION DEFI, INC.","ticker":"HYPD","form_type":"8-K","filed_at":"2026-03-26T23:59:59+00:00","items":["2.02","5.03","7.01","9.01"],"status":"ready","headline":"Hyperion DeFi Q4 rev $496K (+64% QoQ), adj. gross profit $821K (+87%); net loss $38.9M; LOI to sell Optejet","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 revenue $496K (+64% QoQ); Adjusted Gross Profit $821K (+87% QoQ).","Net loss $38.9M vs net income $7.95M in Q3, driven by $36.8M treasury loss on HYPE price decline.","FY 2026 Adjusted Gross Profit guidance $4M–$6M, ~4x FY 2025's $1.28M.","Treasury: 1.93M HYPE, 1.92M KNTQ, 1.0M HPL tokens; Gross HYPE holdings ~$73.4M as of March 23.","Entered LOI to monetize Optejet asset; potential closing in Q2 2026."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":51081607.20277778,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":107219,"accession_number":"0001104659-26-000748","cik":1682639,"company_name":"HYPERION DEFI, INC.","ticker":"HYPD","form_type":"8-K","filed_at":"2026-01-05T23:59:59+00:00","items":["3.02","5.02","7.01","9.01"],"status":"ready","headline":"Hyperion DeFi appoints Hyunsu Jung as permanent CEO; employment agreement through January 2029","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Hyunsu Jung (formerly interim CEO since Sept 2025) named permanent CEO effective Jan 1, 2026; base salary $520K.","Employment agreement provides up to 100% of base salary bonus for 2026 and 12-month severance for non-cause termination.","100,000 shares of Series A Preferred converted into 300,000 common shares on Jan 5, 2026; exempt from registration.","Robert Rubenstein appointed General Counsel effective Jan 12, 2026; brings 30 years of legal and compliance experience.","Board reaffirms 2026 strategic priorities focused on building a Hyperliquid-native DeFi platform."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":51081607.20277778,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":123553,"accession_number":"0001104659-25-119843","cik":1682639,"company_name":"HYPERION DEFI, INC.","ticker":"HYPD","form_type":"8-K","filed_at":"2025-12-10T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"Hyperion DeFi updates risk factors for HYPE treasury strategy, highlights concentration and volatility risks","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["HYPE-heavy treasury strategy exposes assets to extreme price volatility; price decline could materially impact financial condition.","Large holder concentration: 238M+ HYPE tokens held by core contributors; unlock began Nov 29, 2025, increasing selling pressure.","Hyperliquid platform has limited operating history (launched 2023); prior network outage caused slow operations and position closure issues.","Regulatory uncertainty for HYPE and digital assets; potential adverse actions could affect value and transferability.","HiHYPE liquid staking adds additional risks: counterparty, smart contract bugs, valuation volatility vs. HYPE."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":51081607.20277778,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":123552,"accession_number":"0001104659-25-112968","cik":1682639,"company_name":"HYPERION DEFI, INC.","ticker":"HYPD","form_type":"8-K","filed_at":"2025-11-17T23:59:59+00:00","items":["1.01","9.01"],"status":"ready","headline":"Hyperion DeFi enters $500M ATM equity sales agreement with Cantor, Chardan","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Sales Agreement dated Nov 14, 2025 with Cantor Fitzgerald & Co. and Chardan Capital Markets LLC.","Company may sell up to $500M of common stock at-the-market.","Sales agents earn 4.0% commission on gross proceeds.","Company not obligated to sell any shares; agreement terminates upon full sale or termination.","Offering under Form S-3 filed Nov 14, 2025."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":51081607.20277778,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":123551,"accession_number":"0001104659-25-111287","cik":1682639,"company_name":"HYPERION DEFI, INC.","ticker":"HYPD","form_type":"8-K","filed_at":"2025-11-13T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Hyperion DeFi reports record Q3 net income of $6.6M; initiates Q4 guidance of 31-43% QoQ growth","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net income of $6.6M vs ($7.9M) loss in Q3'24; basic EPS $0.26, diluted $0.05.","Revenue rose to $302.5K from $1.6K YoY; adjusted revenue of $361.3K.","Gross HYPE holdings of $77.8M on 1.72M tokens; staked tokens at validator reached 13.2M as of Oct 31.","Q4'25 adjusted revenue guidance $475-515K (31-43% QoQ); management expects positive operating cash flow in 2026."],"consensus_eps_estimate":null,"consensus_eps_actual":-1.64,"consensus_revenue_estimate":null,"consensus_revenue_actual":317226.0,"consensus_period":"2025-Q3","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":51081607.20277778,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":123550,"accession_number":"0001104659-25-104662","cik":1682639,"company_name":"HYPERION DEFI, INC.","ticker":"HYPD","form_type":"8-K","filed_at":"2025-10-31T23:59:59+00:00","items":["1.01","5.02","7.01","8.01","9.01"],"status":"ready","headline":"Hyperion DeFi partners with Felix, allocates 500k HYPE to launch HIP-3 perpetual futures market","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Hyperion entered a Joint Validator Agreement with Kinetiq and Pier Two, staking 10,000 HYPE for a validator node on Hyperliquid.","CEO Michael Rowe's resignation becomes effective November 1, 2025.","HAUS agreement with Felix: Hyperion allocates 500,000 HYPE to a multi-sig wallet to satisfy HIP-3 deployment requirements.","Hyperion receives a share of HIP-3 market trading fees based on volume tiers and 100% of staking rewards.","Felix is a HyperEVM protocol with over $1 billion TVL as of September 2025."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":51081607.20277778,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":123549,"accession_number":"0001104659-25-096051","cik":1682639,"company_name":"HYPERION DEFI, INC.","ticker":"HYPD","form_type":"8-K","filed_at":"2025-10-02T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Director Michael Rowe resigns from Hyperion DeFi Board","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Michael Rowe resigned from the Board of Directors effective September 30, 2025.","No reason for the resignation was provided in the filing.","No successor or replacement director has been announced."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"market_cap_usd":51081607.20277778,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":140234,"accession_number":"0001104659-25-094565","cik":1682639,"company_name":"HYPERION DEFI, INC.","ticker":"HYPD","form_type":"8-K","filed_at":"2025-09-29T23:59:59+00:00","items":["5.02","7.01","9.01"],"status":"ready","headline":"Hyperion DeFi appoints PayPal veteran David Knox as CFO, effective immediately","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["David Knox, former PayPal Head of Capital Markets and Head of Finance for Global Credit & Financial Services, named CFO.","Knox receives $400,000 base salary, $75,000 sign-on bonus, and 100,000 RSU inducement award (vests over 12 months).","Company says appointment strengthens governance and accelerates DeFi strategy, positioning Hyperion as bridge between Wall Street and decentralized finance.","Knox also granted 200,000 milestone-based RSUs under 2018 Omnibus Plan, vesting quarterly upon achievement of targets."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":51081607.20277778,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":140233,"accession_number":"0001104659-25-092748","cik":1682639,"company_name":"HYPERION DEFI, INC.","ticker":"HYPD","form_type":"8-K","filed_at":"2025-09-24T23:59:59+00:00","items":["1.01","9.01"],"status":"ready","headline":"Hyperion DeFi ups ATM offering capacity to $100M; has raised ~$29M to date","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Amended sales agreement with Chardan Capital Markets increases aggregate offering price from $50M to $100M.","As of Sept 24, 2025, company sold 4,176,196 shares for net proceeds of approximately $29.0M under the program.","Amendment dated Sept 24, 2025; shares may be sold under existing S-3 registration statement filed Oct 1, 2024."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":51081607.20277778,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":140232,"accession_number":"0001104659-25-088248","cik":1682639,"company_name":"HYPERION DEFI, INC.","ticker":"HYPD","form_type":"8-K","filed_at":"2025-09-08T23:59:59+00:00","items":["3.01","5.02","9.01"],"status":"ready","headline":"Hyperion DeFi CEO Michael Rowe resigns; Hyunsu Jung named interim CEO; board appoints Happy Walters","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Michael Rowe resigned as CEO effective immediately; Hyunsu Jung (CIO & director) named interim CEO, CFO, Treasurer, and Secretary.","Nasdaq Staff notified company regained compliance with $2.5M minimum equity requirement (Listing Rule 5550(b)(1)).","Board expanded from five to six; Happy Walters appointed as director, effective Sept 8, 2025; granted 50,000 RSUs vesting through Nov 2026.","Walters serves on Nominating & Governance Committee; experience in blockchain and crypto sectors."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":51081607.20277778,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":140231,"accession_number":"0001104659-25-080998","cik":1682639,"company_name":"HYPERION DEFI, INC.","ticker":"HYPD","form_type":"8-K","filed_at":"2025-08-21T23:59:59+00:00","items":["3.03","5.07","9.01"],"status":"ready","headline":"Hyperion DeFi shareholders approve doubling authorized shares; written consent proposal fails","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Authorized common shares doubled from 300M to 600M; preferred from 6M to 60M via charter amendment filed Aug 19.","Stockholder written consent proposal failed (1.01M for, 90k against, 1.78M broker non-votes).","Shareholders approved 5.17M share increase in 2018 Omnibus Stock Incentive Plan and removal of non-employee director limit.","Warrants to institutional investor for up to 394,236 shares approved (993,982 votes for).","Ratification of CBIZ CPAs as auditor for FY2025 (2.78M for, 70k against, 29k abstain)."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":51081607.20277778,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":140230,"accession_number":"0001104659-25-077575","cik":1682639,"company_name":"HYPERION DEFI, INC.","ticker":"HYPD","form_type":"8-K","filed_at":"2025-08-13T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Hyperion DeFi reports Q2 net loss of $8.8M, acquires >1.5M HYPE tokens","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net loss of $8.8M ($2.50 per share) vs $11.1M ($16.65) in Q2 2024; cash $7.5M as of June 30.","Closed $50M private placement; accumulated over 1.5M HYPE tokens as treasury reserve on Hyperliquid blockchain.","Appointed Hyunsu Jung as CIO and Board member; co-branded validator with Kinetiq to earn yield on HYPE.","R&D expenses down 85% to $0.7M; G&A up 104% to $7.7M due to one-time stock grant and higher professional fees.","FDA registration of Optejet User Filled Device remains on track for September 2025."],"consensus_eps_estimate":null,"consensus_eps_actual":-4.29,"consensus_revenue_estimate":null,"consensus_revenue_actual":14720.0,"consensus_period":"2025-Q2","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":51081607.20277778,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":140229,"accession_number":"0001104659-25-065294","cik":1682639,"company_name":"HYPERION DEFI, INC.","ticker":"HYPD","form_type":"8-K","filed_at":"2025-07-02T23:59:59+00:00","items":["5.02","5.03","7.01","9.01"],"status":"ready","headline":"Eyenovia rebrands to Hyperion DeFi, ticker to HYPD; COO departs amid crypto treasury pivot","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Name change from Eyenovia to Hyperion DeFi effective July 1, 2025; new ticker HYPD on Nasdaq July 3.","Company adopts crypto treasury reserve strategy focused on HYPE token; aims to become largest global holder.","COO Bren Kern's employment terminated July 1 (workforce reduction); receives 12 months base salary severance.","Kinetiq x Hyperion validator is live; company staking HYPE holdings to generate yield.","Stockholder approval not needed; CUSIP unchanged."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":51081607.20277778,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":157878,"accession_number":"0001104659-25-063687","cik":1682639,"company_name":"HYPERION DEFI, INC.","ticker":"HYPD","form_type":"8-K","filed_at":"2025-06-27T23:59:59+00:00","items":["7.01","8.01","9.01"],"status":"ready","headline":"Eyenovia pivots to HYPE cryptocurrency treasury; launches validator with Kinetiq","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Eyenovia adopts HYPE as strategic treasury asset; first US public company to do so.","Co-branded Hyperliquid validator with Kinetiq; staking and HyperEVM yield strategies planned.","Supplements risk factors: HYPE volatility, regulatory uncertainty, potential impairment charges.","Company to deploy portion of capital into HYPE while continuing Optejet development.","Validator operations supported by Pier Two; aims to generate revenue from delegation benefits."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":51081607.20277778,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":157877,"accession_number":"0001104659-25-062095","cik":1682639,"company_name":"HYPERION DEFI, INC.","ticker":"HYPD","form_type":"8-K","filed_at":"2025-06-24T23:59:59+00:00","items":["1.01","5.03","2.03","3.02","5.02","7.01","9.01"],"status":"ready","headline":"Eyenovia raises $50M to acquire HYPE tokens, shifts to crypto treasury strategy; appoints new CIO","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["$50M PIPE for HYPE tokens; warrants could raise ~$150M more if exercised at $3.25/share.","Hyunsu Jung appointed CIO and board member; three directors resigned per investor agreement.","Loan amended: maturity extended to July 2028, interest rate cut to 8% (half PIK), interest-only through Jan 2027.","Company expects to rename to Hyperion DeFi and change ticker to HYPD.","Gen-2 Optejet device still in development; FDA registration anticipated by September 2025."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":51081607.20277778,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":157876,"accession_number":"0001104659-25-056679","cik":1682639,"company_name":"HYPERION DEFI, INC.","ticker":"HYPD","form_type":"8-K","filed_at":"2025-06-05T23:59:59+00:00","items":["1.01","9.01"],"status":"ready","headline":"Eyenovia amends loan agreement to cap lender beneficial ownership at 9.99% on up to $10M conversion at $1.68/share","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Third Amendment caps lender beneficial ownership at 9.99% (adjustable to 19.99% with 61-day notice) on conversion of up to $10M principal.","Conversion price unchanged at $1.68 per share for up to $10M aggregate principal under existing $15M loan facility.","Lenders granted anti-dilution protections in fundamental transactions (merger, asset sale, recap), entitling them to same consideration as common shareholders."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":51081607.20277778,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":157875,"accession_number":"0001104659-25-050528","cik":1682639,"company_name":"HYPERION DEFI, INC.","ticker":"HYPD","form_type":"8-K","filed_at":"2025-05-19T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Eyenovia Reports Q1 2025 Financial Results, Provides Merger and Optejet Development Update","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net loss narrowed to $3.5 million ($1.59 per share) versus $10.9 million ($18.75 per share) in Q1 2024.","Continuing merger negotiations with Betaliq; binding exclusivity extended to June 7, 2025.","Optejet user-filled device on track to file for FDA device approval in September 2025.","Cash burn reduced by approximately 70% versus prior year; debt restructuring with Avenue Capital defers payments to October 2025.","Unrestricted cash and equivalents totaled $3.9 million as of March 31, 2025."],"consensus_eps_estimate":-9.792,"consensus_eps_actual":-1.59,"consensus_revenue_estimate":null,"consensus_revenue_actual":14720.0,"consensus_period":"2025-Q1","consensus_source":"xbrl+finnhub","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":51081607.20277778,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":157874,"accession_number":"0001104659-25-044238","cik":1682639,"company_name":"HYPERION DEFI, INC.","ticker":"HYPD","form_type":"8-K","filed_at":"2025-05-02T23:59:59+00:00","items":["4.01","9.01"],"status":"ready","headline":"Eyenovia appoints CBIZ CPAs as auditor after Marcum resignation; going concern flagged","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Marcum LLP resigned as independent auditor; CBIZ CPAs P.C. engaged effective May 2, 2025.","No adverse opinions or disagreements; audit reports for 2024 and 2023 included going concern emphasis.","Company disclosed two material weaknesses as of Dec 31, 2024, currently being remediated.","No prior consultations with CBIZ CPAs on accounting principles or audit opinions."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":51081607.20277778,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":157873,"accession_number":"0001104659-25-044223","cik":1682639,"company_name":"HYPERION DEFI, INC.","ticker":"HYPD","form_type":"8-K","filed_at":"2025-05-02T23:59:59+00:00","items":["3.01"],"status":"ready","headline":"Eyenovia receives Nasdaq deficiency notice for equity below $2.5M minimum","summary_kind":"llm","event_type":"regulatory","confidence":"high","bullets":["Nasdaq notified Eyenovia that stockholders' equity as of Dec 31, 2024 was below the $2.5M minimum required.","Company has 45 days (until June 13, 2025) to submit a compliance plan to Nasdaq.","If plan accepted, Nasdaq may grant up to 180 days (until Oct 26, 2025) to regain compliance.","Company intends to submit a plan; stock continues trading on Nasdaq under EYEN.","Failure to regain compliance could lead to delisting from Nasdaq Capital Market."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":51081607.20277778,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":176265,"accession_number":"0001104659-25-026120","cik":1682639,"company_name":"HYPERION DEFI, INC.","ticker":"HYPD","form_type":"8-K","filed_at":"2025-03-20T23:59:59+00:00","items":["2.02","8.01","9.01"],"status":"ready","headline":"Eyenovia enters non-binding LOI for reverse merger with Betaliq; EYEN holders to own ~16.3%","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Reverse merger: Betaliq stockholders would own ~83.7% of combined company; Eyenovia holders ~16.3% on fully diluted basis.","Betaliq valued at ~$77M, Eyenovia at ~$15M (net cash zero at close); Eyenovia had $2.1M cash as of Dec 31, 2024.","Exclusivity period ends May 16, 2025; conditions include due diligence, definitive agreement, board approvals, and financing.","Combined company would continue marketing Eyenovia's FDA-approved products and leverage EyeSol+Optejet technologies.","Eyenovia expects to change name to Betaliq and update trading symbol; no assurance deal will close."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":51081607.20277778,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":176264,"accession_number":"0001104659-25-016919","cik":1682639,"company_name":"HYPERION DEFI, INC.","ticker":"HYPD","form_type":"8-K","filed_at":"2025-02-25T23:59:59+00:00","items":["8.01"],"status":"ready","headline":"Eyenovia regains Nasdaq minimum bid compliance after reverse stock split","summary_kind":"llm","event_type":"regulatory","confidence":"high","bullets":["Nasdaq notified Eyenovia on Feb 25, 2025 that it regained compliance with the $1.00 minimum bid requirement as of Feb 20.","Company had faced delisting after bid price fell below $0.10 for 10 consecutive days in Dec 2024.","Compliance achieved through a reverse stock split effective Jan 31, 2025, as disclosed in prior 8-K.","Nasdaq originally granted exception until Feb 14, 2025; stock will continue trading on Nasdaq Capital Market.","Bid price cure period initially ran to March 17, 2025, but was superseded by low-priced stock rule."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":51081607.20277778,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":176263,"accession_number":"0001104659-25-016375","cik":1682639,"company_name":"HYPERION DEFI, INC.","ticker":"HYPD","form_type":"8-K","filed_at":"2025-02-24T23:59:59+00:00","items":["1.01","2.03","9.01"],"status":"ready","headline":"Eyenovia amends loan agreement, defers payments through Sep 2025, grants $10M conversion option at $1.68","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Deferred principal and interest payments until Sept 30, 2025; interest rate is prime + 4.45% (floor 7%).","Must use 65% (then 75%) of net proceeds from Chardan ATM to repay outstanding principal.","Lenders can convert up to $10M principal into common stock at $1.68/share starting Apr 1, 2025.","Outstanding principal under facility was $10.3M as of Feb 21, 2025; maturity remains Nov 1, 2025.","Deferred interest during first deferral period was added to principal; second deferral accrues unpaid cash interest."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":51081607.20277778,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":176262,"accession_number":"0001104659-25-008090","cik":1682639,"company_name":"HYPERION DEFI, INC.","ticker":"HYPD","form_type":"8-K","filed_at":"2025-01-31T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"Eyenovia files 1-for-80 reverse stock split to regain Nasdaq minimum bid compliance","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Reverse stock split 1-for-80 effective Jan 31, 2025 at 4:00 p.m. ET.","Stock to trade on split-adjusted basis on Nasdaq starting Feb 3, 2025, symbol EYEN unchanged.","Amendment filed to regain compliance with Nasdaq minimum bid price requirement.","No fractional shares issued; cash payments for fractional shares.","New CUSIP for common stock following reverse split: 30234E 203."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":51081607.20277778,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":176261,"accession_number":"0001104659-25-006697","cik":1682639,"company_name":"HYPERION DEFI, INC.","ticker":"HYPD","form_type":"8-K","filed_at":"2025-01-28T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"Eyenovia announces 1-for-80 reverse stock split effective Jan 31, 2025 to regain Nasdaq bid price compliance","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Reverse split at 1-for-80 ratio reduces outstanding shares from ~167.5M to ~2.1M; effective 4:00 pm ET Jan 31, 2025.","Post-split trading on Nasdaq under same symbol EYEN with new CUSIP 30234E 203 from Feb 3, 2025.","Split intended to regain Nasdaq minimum bid price compliance; company continues evaluating strategic alternatives.","Proportionate adjustments to stock options/warrants; fractional shares paid in cash, no change in authorized shares."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":51081607.20277778,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":176260,"accession_number":"0001104659-25-005978","cik":1682639,"company_name":"HYPERION DEFI, INC.","ticker":"HYPD","form_type":"8-K","filed_at":"2025-01-24T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"Eyenovia shareholders approve reverse stock split (1:40-1:80) and share issuances","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Reverse stock split amendment approved with 45.3M votes for, 12.6M against; ratio between 1:40 and 1:80.","Amendment to 2018 Omnibus Stock Incentive Plan to reserve 350,000 additional shares approved.","Potential issuance of up to 73M shares upon exercise of Purchase Warrants approved under Nasdaq Rule 5635(d).","All three proposals passed; broker non-votes present only on proposals 2 and 3."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":51081607.20277778,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":176259,"accession_number":"0001104659-25-004007","cik":1682639,"company_name":"HYPERION DEFI, INC.","ticker":"HYPD","form_type":"8-K","filed_at":"2025-01-16T23:59:59+00:00","items":["1.01","3.02","9.01"],"status":"ready","headline":"Eyenovia induces warrant exercise raising $1.0M; issues new warrants with 200% coverage at $0.0659","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Investor exercised 15,769,445 existing warrants at reduced price of $0.0659, gross proceeds ~$1.0M.","Issued Series A and B warrants to purchase up to 31.5M shares (200% coverage) at $0.0659 per share.","New warrants require stockholder approval before exercisable; meeting to be held within 120 days.","Company must file resale registration statement for new warrant shares by Feb 28, 2025; effective within 120 days of issuance.","Chardan Capital received 4.5% cash fee on gross proceeds for financial advisory."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":51081607.20277778,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":193154,"accession_number":"0001104659-24-132482","cik":1682639,"company_name":"HYPERION DEFI, INC.","ticker":"HYPD","form_type":"8-K","filed_at":"2024-12-30T23:59:59+00:00","items":["1.01","8.01","9.01"],"status":"ready","headline":"Eyenovia replaces ATM agent, reports $2.2M cash vs $10.1M debt","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["New ATM agreement with Chardan Capital Markets for up to $50M, replacing Leerink Partners; 3% commission.","Prior ATM with Leerink terminated; $16.4M in shares sold under that program.","Cash and cash equivalents as of Dec 26, 2024: $2.2 million.","Outstanding debt under Avenue Capital loan: $10.1 million principal and accrued interest."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":51081607.20277778,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":193153,"accession_number":"0001104659-24-128428","cik":1682639,"company_name":"HYPERION DEFI, INC.","ticker":"HYPD","form_type":"8-K","filed_at":"2024-12-13T23:59:59+00:00","items":["3.01"],"status":"ready","headline":"Eyenovia receives Nasdaq delisting notice due to low stock price; plans to appeal","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Nasdaq determined to delist Eyenovia's common stock because closing bid price was $0.10 or less for 10 consecutive trading days as of December 11, 2024.","The Bid Price Cure Period (until March 17, 2025) was rendered unavailable by the Low Priced Stocks Rule.","Eyenovia intends to appeal the delisting determination by December 19, 2024; appeal will stay suspension pending a Hearings Panel decision.","On December 12, 2024, filed preliminary proxy for a special meeting on January 21, 2025 to approve a reverse stock split to regain compliance.","No assurance of favorable decision from Nasdaq or that reverse split will increase stock price."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.95,"calibrated_materiality_score":0.95,"market_cap_usd":51081607.20277778,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":193152,"accession_number":"0001104659-24-126533","cik":1682639,"company_name":"HYPERION DEFI, INC.","ticker":"HYPD","form_type":"8-K","filed_at":"2024-12-09T23:59:59+00:00","items":["1.01","7.01","9.01"],"status":"ready","headline":"Eyenovia raises $1.9M via registered direct offering of common stock and warrants at $0.0969/share","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Offering of 20,085,025 shares/pre-funded warrants and 40,170,050 warrants, combined price $0.0969 per unit.","Gross proceeds ~$1.9M; net proceeds for working capital, partial debt repayment to Avenue Capital, and Optejet device advancement.","CEO: Gen-2 Optejet device registration expected in US in Q3 2025; restructuring underway to right-size organization.","Warrants exercisable at $0.0969/share, starting 6 months or upon stockholder approval, 5-year term."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":51081607.20277778,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":193151,"accession_number":"0001104659-24-122846","cik":1682639,"company_name":"HYPERION DEFI, INC.","ticker":"HYPD","form_type":"8-K","filed_at":"2024-11-26T23:59:59+00:00","items":["1.01","7.01","9.01"],"status":"ready","headline":"Eyenovia prices $1.3M registered direct offering of 12M shares plus warrants at $0.1076/share","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Offering consists of 12,081,785 shares/pre-funded warrants and 24,163,570 warrants; combined price $0.1076 per share+accompanying warrant.","Gross proceeds ~$1.3M; net proceeds for working capital, partial Avenue Capital loan repayment, Optejet advancement, Mydcombi/commercialization.","Warrants exercisable at $0.1076, beginning six months from issuance, expiring May 26, 2030 (5 years).","Closing expected November 26, 2024; placement agent Chardan Capital Markets."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":51081607.20277778,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":193150,"accession_number":"0001104659-24-122380","cik":1682639,"company_name":"HYPERION DEFI, INC.","ticker":"HYPD","form_type":"8-K","filed_at":"2024-11-25T23:59:59+00:00","items":["1.01","2.03","3.02","5.02","9.01"],"status":"ready","headline":"Eyenovia amends debt facility, issues 1.9M shares to lenders, CFO resigns","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["First Amendment defers principal & interest payments on $10.1M facility until end of Feb 2025; deferred interest added to principal.","Issued 1,901,733 shares to lenders at ~$0.1052/sh (based on VWAP) as part of the amendment, raising $200k.","CFO Andrew Jones departed Nov 22; CEO Michael Rowe appointed Principal Financial Officer, Treasurer, Secretary.","Jones will serve as part-time consultant through Dec 31, 2024, receiving $20,000."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":51081607.20277778,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":193149,"accession_number":"0001104659-24-120867","cik":1682639,"company_name":"HYPERION DEFI, INC.","ticker":"HYPD","form_type":"8-K","filed_at":"2024-11-20T23:59:59+00:00","items":["8.01"],"status":"ready","headline":"Eyenovia reports $0.7M cash, $10.1M debt; in restructuring talks with Avenue Capital","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Cash and cash equivalents of $0.7M as of November 19, 2024; $10.1M principal and accrued interest due under Loan and Security Agreement.","Loan interest rate is greater of 7.0% or prime rate plus 4.45%; maturity date November 1, 2025.","Company in discussions with Avenue Capital Management to restructure the outstanding debt.","Also evaluating strategic options including business combination, reverse merger, or asset sales.","Significant liquidity shortfall raises going-concern risk without restructuring or new capital."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":51081607.20277778,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":193148,"accession_number":"0001104659-24-119760","cik":1682639,"company_name":"HYPERION DEFI, INC.","ticker":"HYPD","form_type":"8-K","filed_at":"2024-11-15T23:59:59+00:00","items":["2.05","8.01","9.01"],"status":"ready","headline":"Eyenovia Phase 3 CHAPERONE myopia trial fails; cuts 50% staff, explores strategic options","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Independent DRC found CHAPERONE not meeting primary endpoint of <0.5 diopter progression over 3 years; study terminated.","252 evaluable patients; no significant difference between active arms (0.01% and 0.1% atropine) and placebo.","Workforce reduction of ~50% with $0.2M severance; remaining staff focused on Optejet Gen-2, dry eye collaborations, clobetasol.","Company evaluating strategic options: business combination, reverse merger, or asset sales.","Safety profile acceptable; mild and infrequent adverse events across all doses."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.9,"calibrated_materiality_score":0.9,"market_cap_usd":51081607.20277778,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":193147,"accession_number":"0001104659-24-116782","cik":1682639,"company_name":"HYPERION DEFI, INC.","ticker":"HYPD","form_type":"8-K","filed_at":"2024-11-12T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Eyenovia Q3 2024 net loss $7.9M; advances MicroPine Phase 3 and launches clobetasol","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net loss of $7.9M ($0.11/share) vs $7.3M ($0.18/share) in Q3 2023; SG&A up 27% to $3.7M.","Cash & equivalents $7.2M at Sept 30, 2024; evaluating long-term financing options.","Phase 3 CHAPERONE (MicroPine) interim analysis planned this quarter; myopia market >$3B annually.","U.S. launch of clobetasol propionate 0.05% for post-surgical ocular inflammation/pain.","Mydcombi shipped to 230 new offices since April; appointed Andrew Jones as CFO; raised $10.7M net."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.53,"consensus_revenue_estimate":null,"consensus_revenue_actual":29243.0,"consensus_period":"2024-Q3","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":51081607.20277778,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":209530,"accession_number":"0001104659-24-103959","cik":1682639,"company_name":"HYPERION DEFI, INC.","ticker":"HYPD","form_type":"8-K","filed_at":"2024-09-30T23:59:59+00:00","items":["1.01","7.01","9.01"],"status":"ready","headline":"Eyenovia prices $4M registered direct offering of common stock and warrants at $0.46/unit","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["8,695,653 shares (or equivalents) and 8,695,653 warrants sold at $0.46 per share and accompanying warrant.","Gross proceeds ~$4M; closing expected September 30, 2024.","Warrants exercisable at $0.50/share, begin 6 months post-issuance, expire March 2030.","Net proceeds for Mydcombi and clobetasol commercialization, CHAPERONE myopia study, working capital, possible debt repayment.","Lead placement agent A.G.P./Alliance Global Partners; co-agent Brookline Capital Markets."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":51081607.20277778,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":209529,"accession_number":"0001104659-24-101686","cik":1682639,"company_name":"HYPERION DEFI, INC.","ticker":"HYPD","form_type":"8-K","filed_at":"2024-09-20T23:59:59+00:00","items":["3.01"],"status":"ready","headline":"Eyenovia receives Nasdaq bid price deficiency notice; has until March 17, 2025 to regain compliance","summary_kind":"llm","event_type":"regulatory","confidence":"high","bullets":["Received Nasdaq deficiency letter on Sept 18, 2024; bid price below $1.00 for 30 consecutive business days.","Initial compliance period ends March 17, 2025; must close at $1.00+ for 10 consecutive business days.","If not cured, may qualify for additional 180-day period if meeting other listing standards.","Stock continues trading under symbol 'EYEN' on Nasdaq Capital Market."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":51081607.20277778,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":209528,"accession_number":"0001104659-24-095993","cik":1682639,"company_name":"HYPERION DEFI, INC.","ticker":"HYPD","form_type":"8-K","filed_at":"2024-09-03T23:59:59+00:00","items":["5.02","7.01","9.01"],"status":"ready","headline":"Eyenovia appoints Andrew Jones as CFO; John Gandolfo retires through Nov 2024","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["John Gandolfo retired as CFO, Treasurer, and Secretary on Aug 30, 2024; will remain an employee through Nov 30, 2024 for transition.","Andrew D. Jones appointed CFO, Treasurer, and Secretary, effective Aug 30, 2024; prior CFO of NovaBay Pharmaceuticals (NBY).","Jones receives $440k base salary, target cash bonus of 40% of base, and inducement option for 200k shares vesting over 4 years.","Jones' employment agreement provides severance of 12 months base salary plus benefits if terminated without cause or after change in control."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":51081607.20277778,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":209527,"accession_number":"0001104659-24-092228","cik":1682639,"company_name":"HYPERION DEFI, INC.","ticker":"HYPD","form_type":"8-K","filed_at":"2024-08-23T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Eyenovia posts updated corporate presentation; no material new details disclosed","summary_kind":"llm","event_type":"other","confidence":"low","bullets":["Eyenovia released an updated corporate investor presentation on August 23, 2024.","Presentation focuses on topical ophthalmic therapies for easier administration.","No financial results, guidance changes, or pipeline milestones were disclosed."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"market_cap_usd":51081607.20277778,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":209526,"accession_number":"0001104659-24-091829","cik":1682639,"company_name":"HYPERION DEFI, INC.","ticker":"HYPD","form_type":"8-K","filed_at":"2024-08-22T23:59:59+00:00","items":["1.01","7.01","9.01"],"status":"ready","headline":"Eyenovia prices public offering of 12.85M shares at $0.40 for ~$5.14M gross proceeds","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Priced 12,850,000 common shares at $0.40 per share; expected to close August 22, 2024.","Gross proceeds of approximately $5.14 million before fees and expenses.","Proceeds to fund Mydcombi and clobetasol propionate commercialization, CHAPERONE pediatric myopia study, and general corporate purposes.","May also repay portion of existing indebtedness under Loan and Security Agreement with Avenue Capital Management.","Dawson James Securities acting as sole placement agent; offering made under existing S-3 shelf registration."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":51081607.20277778,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":209525,"accession_number":"0001104659-24-088942","cik":1682639,"company_name":"HYPERION DEFI, INC.","ticker":"HYPD","form_type":"8-K","filed_at":"2024-08-13T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Eyenovia Q2 net loss $11.1M; plans Gen-2 Optejet submission 2025 with Mydcombi","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net loss $11.1M ($0.21/share) vs $6.2M ($0.16/share) in Q2 2023; includes $2.9M MicroPine license reacquisition expense.","Cash $2.3M at June 30; $5.8M gross equity proceeds after quarter; expects funding through Phase 3 CHAPERONE data.","Following FDA meeting, plans Gen-2 Optejet validation in Q4 2024 and regulatory submission 2025 with Mydcombi as lead.","Phase 3 CHAPERONE study of MicroPine; analysis expected Q4 2024.","Mydcombi launched in 63 new offices; targeting 263 by Q3 end; dry eye collaborations with Formosa, Senju, SGN."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.44,"consensus_revenue_estimate":null,"consensus_revenue_actual":27618.0,"consensus_period":"2024-Q2","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":51081607.20277778,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":209524,"accession_number":"0001104659-24-083255","cik":1682639,"company_name":"HYPERION DEFI, INC.","ticker":"HYPD","form_type":"8-K","filed_at":"2024-07-29T23:59:59+00:00","items":["8.01"],"status":"ready","headline":"Eyenovia regains Nasdaq minimum bid price compliance after 10-day stretch over $1.00","summary_kind":"llm","event_type":"regulatory","confidence":"high","bullets":["Received Nasdaq confirmation on July 26, 2024 that compliance with Listing Rule 5550(a)(2) is regained.","Previously notified of non-compliance on July 2, 2024 with 180-day cure period through Dec 30, 2024.","Closing bid price at or above $1.00 for the ten consecutive business days from July 12 to July 25, 2024.","Company avoids delisting from Nasdaq Capital Market; no further bid-price deficiency action required."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":51081607.20277778,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":209523,"accession_number":"0001104659-24-078085","cik":1682639,"company_name":"HYPERION DEFI, INC.","ticker":"HYPD","form_type":"8-K","filed_at":"2024-07-05T23:59:59+00:00","items":["3.01"],"status":"ready","headline":"Eyenovia receives Nasdaq deficiency notice for bid price below $1.00 per share","summary_kind":"llm","event_type":"regulatory","confidence":"high","bullets":["Nasdaq notified Eyenovia that its common stock closed below $1.00 for 30 consecutive business days.","Company has 180 calendar days, until December 30, 2024, to regain compliance by maintaining $1.00 or higher for 10 consecutive days.","If not compliant by December 30, 2024, Eyenovia may qualify for an additional 180-day period subject to meeting other listing standards.","Stock continues to trade on Nasdaq Capital Market under symbol EYEN during the cure period.","Eyenovia intends to monitor bid price and consider available options to regain compliance."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":51081607.20277778,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":209522,"accession_number":"0001104659-24-076581","cik":1682639,"company_name":"HYPERION DEFI, INC.","ticker":"HYPD","form_type":"8-K","filed_at":"2024-07-01T23:59:59+00:00","items":["1.01","7.01","9.01"],"status":"ready","headline":"Eyenovia raises ~$5M via registered direct offering of shares and warrants; amends prior warrants","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Offering of 7,575,757 shares plus warrants to purchase 7,575,757 shares at $0.66 per unit.","Gross proceeds ~$5M; net to fund Mydcombi/clobetasol commercialization and CHAPERONE study.","Warrants exercisable at $0.69, 6-month lockout, expire Jan 2, 2030.","Prior warrants for ~10.4M shares amended: exercise price cut from ~$2.22 to $0.69, term extended to Jan 1, 2030.","Placement agents: Chardan Capital Markets and Brookline Capital Markets; closing expected July 1, 2024."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":51081607.20277778,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":227612,"accession_number":"0001104659-24-071527","cik":1682639,"company_name":"HYPERION DEFI, INC.","ticker":"HYPD","form_type":"8-K","filed_at":"2024-06-14T23:59:59+00:00","items":["3.03","5.07","9.01"],"status":"ready","headline":"Eyenovia shareholders approve increase in authorized common stock from 90M to 300M","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Charter amendment to increase authorized common shares from 90M to 300M approved by 19.6M for, 6.9M against, 2.7M abstain.","All seven director nominees elected with 12.2M-12.9M votes for; broker non-votes 15.6M.","Ratification of Marcum LLP as auditor for FY2024 passed with 28.0M for, 0.9M against, 0.3M abstain.","Advisory say-on-pay approved with 12.2M for, 1.2M against; frequency set to annual based on vote.","Approximately 57.2% of eligible shares represented at meeting; 29.2M shares of 51.0M outstanding."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":51081607.20277778,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":227611,"accession_number":"0001104659-24-068055","cik":1682639,"company_name":"HYPERION DEFI, INC.","ticker":"HYPD","form_type":"8-K","filed_at":"2024-06-04T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Eyenovia updates corporate presentation; MicroPine interim readout 4Q 2024, Clobetasol launch 3Q 2024","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["MicroPine Phase 3 CHAPERONE interim DMC review expected 4Q 2024; SAE rate <1 per 1,000 patient-months, all unrelated.","Clobetasol propionate 0.05% launch expected 3Q 2024; projected 3rd-year sales $50M; co-promotion with NovaBay for Avenova.","Optejet Gen-2 FDA meeting planned 3Q 2024 to confirm pathway for drug/device; licensing targets dry eye and glaucoma (>$8.8B market).","MicroPine potential peak US sales >$1B by 2036; net price $200/month, COGS <$20; addresses ~5M high-risk myopic children.","Optecare digital compliance system built into Optejet to track adherence; aims to improve patient outcomes and differentiate."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":51081607.20277778,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null}],"next_cursor":"2024-06-04T23:59:59+00:00|227611"}